Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Heart Failure VI: Adjunct Therapies

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

Heart Failure V: Medical Management

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...

Heart Failure VII: Nursing Interventions

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...

Cardiomyopathy II: Dilated Cardiomyopathy

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

Continuing Care

Continuing Care

Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Beyond Guideline-Directed Medical Therapy: Nonpharmacologic Management for Patients With Heart Failure.

JACC. Heart failure·2024

Same author

Design, Creation, and 13-Month Performance of a Novel, Web-Based Activity for Education in Primary Cardiology Palliative Care.

Journal of pain and symptom management·2024

Same author

Multidomain Approach to Integration of Heart Failure and Palliative Care.

Circulation. Cardiovascular quality and outcomes·2024

Same author

Cardiogenic Shock in Older Adults: A Focus on Age-Associated Risks and Approach to Management: A Scientific Statement From the American Heart Association.

Circulation·2024

Same author

Perioperative Factors Associated With Postoperative Delirium in Patients Undergoing Noncardiac Surgery: An Individual Patient Data Meta-Analysis.

JAMA network open·2023

Same author

Intersection of Palliative Care and Hospice Use Among Patients With Advanced Lung Cancer.

Journal of palliative medicine·2023

Search research articles

Related Experiment Videos

Palliative care in congestive heart failure.

Sarah J Goodlin¹

¹Patient-Centered Education and Research, 681 East 17th Avenue, Salt Lake City, Utah 84103, USA. sjg-pcer@comcast.net

Journal of the American College of Cardiology

|July 25, 2009

Summary

Palliative care is crucial for heart failure (HF) patients, addressing symptoms and improving quality of life. Integrating palliative measures with evidence-based HF care optimizes patient outcomes and end-of-life planning.

Related Experiment Videos

Area of Science:

Cardiology
Palliative Medicine
Quality of Life Research

Background:

Heart failure (HF) significantly impacts patients' quality of life, necessitating dedicated palliative interventions.
Neurohormonal and catabolic dysfunctions are primary drivers of HF symptoms and distress.
Current HF care often lacks comprehensive integration of palliative measures.

Purpose of the Study:

To emphasize the importance of integrating palliative care into the comprehensive management of heart failure.
To highlight interventions that can alleviate symptoms and improve the quality of life for HF patients.
To advocate for proactive planning regarding prognosis and end-of-life care in heart failure.

Main Methods:

Review of existing literature on palliative care in heart failure.
Identification of interventions targeting neurohormonal derangements and catabolic processes.
Analysis of strategies for managing patient and family perceptions of control and communication about prognosis.

Main Results:

Palliative measures, including exercise, opioids, and sleep apnea treatment, can address HF symptoms.
Integrating evidence-based HF care into end-of-life planning is essential.
Proactive communication strategies are needed to discuss prognosis with patients and families.

Conclusions:

Palliative care should be an integral component of heart failure management.
Further research is required to guide end-of-life HF medication use and manage complex patient distress.
Addressing symptoms and quality of life is paramount throughout the HF continuum.